{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Primary membranoproliferative glomerulonephritis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_angiotensin_converting_enzyme_inhibitors",
          "name": "Angiotensin converting enzyme inhibitors"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_angiotensin_receptor_blockers",
          "name": "Angiotensin receptor blockers"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_intravenous_immunoglobulin",
          "name": "Intravenous immunoglobulin"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_furosemide",
          "name": "Furosemide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_mpgn",
          "type": "Disease",
          "label": "Primary membranoproliferative glomerulonephritis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cortico",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_mycophenolate",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ace_inhibitors",
          "type": "Drug",
          "label": "Angiotensin converting enzyme inhibitors",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_arbs",
          "type": "Drug",
          "label": "Angiotensin receptor blockers",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ivig",
          "type": "Drug",
          "label": "Intravenous immunoglobulin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_furosemide",
          "type": "Drug",
          "label": "Furosemide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_statins",
          "type": "Drug",
          "label": "Statins",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "Off-target mechanism",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp1",
          "type": "Pathway",
          "label": "Risk pathway linked to immunosuppression",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Increased infection risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv2",
          "type": "Phenotype",
          "label": "Nephrotoxicity",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "n_cortico",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能作用于非靶点，影响免疫恢复"
        },
        {
          "source": "n_rituximab",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在免疫抑制过度，增加感染风险"
        },
        {
          "source": "n_mycophenolate",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "长期使用可能引起肾损伤"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能引发多种并发症"
        },
        {
          "source": "n_azathioprine",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可引起骨髓抑制，感染风险增加"
        },
        {
          "source": "n_plasmapheresis",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "不确定长期效果，较少数据支持"
        },
        {
          "source": "n_eculizumab",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "成本高，罕见适应症"
        },
        {
          "source": "n_ace_inhibitors",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能与其他药物反应"
        },
        {
          "source": "n_arbs",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "潜在的肾功能影响"
        },
        {
          "source": "n_ivig",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能导致不良免疫反应"
        },
        {
          "source": "n_furosemide",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "会对肾功能造成影响"
        },
        {
          "source": "n_statins",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "肾脏代谢潜在影响"
        },
        {
          "source": "n_ot1",
          "target": "n_rp1",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "免疫抑制剂的非靶向作用与风险通路相关"
        },
        {
          "source": "n_rp1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "提高感染风险"
        },
        {
          "source": "n_rp1",
          "target": "n_adv2",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致肾脏相关并发症"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "感染风险增加将抵消利用 corticosteroids 的净收益"
        },
        {
          "source": "n_adv2",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "肾损伤风险抵消了潜在益处"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": [
        {
          "topic": "免疫抑制与感染风险",
          "pro_nodes": [
            "n_cortico",
            "n_rituximab"
          ],
          "con_nodes": [
            "n_adv1"
          ],
          "note": "免疫抑制对急性症状有益，但长期结果可能相反"
        },
        {
          "topic": "肾功能与药物毒性",
          "pro_nodes": [
            "n_mycophenolate",
            "n_cyclophosphamide"
          ],
          "con_nodes": [
            "n_adv2"
          ],
          "note": "需权衡效果与潜在的肾脏损伤风险"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在增强感染风险的机制链，可能抵消益处",
        "confidence": "high"
      },
      {
        "id": "K2",
        "text": "肾毒性可能导致长期并发症，显著影响生存质量",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "免疫抑制在该疾病的作用是否足够明确",
      "药物间相互作用可能影响疗效与安全性"
    ],
    "falsification_tests": [
      "是否有针对不同药物与感染风险的具体数据？",
      "长期临床试验是否证实免疫抑制的有效性？"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供机制明确的有效性证据",
      "针对冲突热点提供补充数据或替代策略"
    ]
  }
}